Quat Wipes Provide Broad-Spectrum Disinfection

VersaSure kills influenza, measles, mumps, respiratory syncytial virus (RSV), and other viruses in 30 seconds. Bacteria and fungi, including methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin resistant Enterococcus faecalis (VRE), Escherichia coli (E. coli), salmonella, mycobacterium bovis (TB), and Candida albicans are eradicated in two minutes.

The patented alcohol-free quat technology and innovative wipe design combine to provide excellent aesthetics and cleaning power, delivering broad efficacy and fast kill times without co-active complexes. The low residue formula provides superior staff and patient comfort, with no harsh chemical fumes or odors. The durable, low-linting wipes are textured for greater strength, with excellent wetness that provides high surface coverage, assuring that the treated surfaces will remain wet for the full contact time.

“Not all disinfectants are created equal, and many don’t have the optimal balance of attributes to meet users’ needs. For example, a conventional quat or alcohol-based product might offer good compatibility, but have limited kill claims or evaporate from surfaces before meeting the required contact time,” said Brian Thompson, director of Clorox Healthcare R&D. “We believe healthcare facilities shouldn’t have to make those trade-offs, and with VersaSure, they don’t. Our R&D teams refused to make compromises between efficacy, aesthetics, wetness and cleaning power.”

VersaSure wipes are ready-to-use, fast acting and compatible with a broad range of hard, non-porous surfaces found in healthcare settings. A variety of sizes are available, including multipurpose wipes in 85 and 150 count canisters and 30 count flat packs, terminal wipes for everyday cleaning and disinfecting of large spaces, 110 count buckets, and refill pouches.

Related Links:
Clorox Healthcare